M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 1.8 USD -5.76% Market Closed
Market Cap: 85.1m USD
Have any thoughts about
MDxHealth SA?
Write Note

MDxHealth SA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MDxHealth SA
Cost of Revenue Peer Comparison

Comparables:
GLPG
OXUR
CYAD

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
M
MDxHealth SA
NASDAQ:MDXH
Cost of Revenue
-$44.7m
CAGR 3-Years
-61%
CAGR 5-Years
-33%
CAGR 10-Years
-18%
Galapagos NV
AEX:GLPG
Cost of Revenue
-€24.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Oxurion NV
XBRU:OXUR
Cost of Revenue
-€159k
CAGR 3-Years
34%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Celyad Oncology SA
XBRU:CYAD
Cost of Revenue
-€34k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MDxHealth SA's Cost of Revenue?
Cost of Revenue
-44.7m USD

Based on the financial report for Jun 30, 2024, MDxHealth SA's Cost of Revenue amounts to -44.7m USD.

What is MDxHealth SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-18%

Over the last year, the Cost of Revenue growth was -53%. The average annual Cost of Revenue growth rates for MDxHealth SA have been -61% over the past three years , -33% over the past five years , and -18% over the past ten years .

Back to Top